Clinical Trials Logo

Clinical Trial Summary

MASTER study is a 4-year prospective, randomized, open-label, blinded-endpoint study (PROBE) comparing 2 management strategies 1) office BP as a guide to treatment, or 2) 24-hour ABP as a guide to treatment. Study objectives are to investigate whether a management strategy based on out-of-office BP (Ambulatory BP monitoring) versus a management strategy based on office BP measurements is associated with differences in outcome, including cardiovascular and renal intermediate end points at one year; cardiovascular events at 4 years and changes in a number of blood pressure-related variables throughout the study. Patients will be followed-up during the first year focusing on changes in left ventricular mass index (LVMI, co-primary endpoint) and Urinary albumin excretion (UAE, albumin/creatinine ratio, co-primary end-point), and during the whole 48 month period for both changes in LVMI and UAE and events including all-cause mortality, CV morbidity and mortality, cerebral morbidity and mortality.A total of 1240 subjects will be recruited by 30 centers, taking into account a dropout rate of 15% (620 subjects per randomization arm).


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02804074
Study type Interventional
Source Istituto Auxologico Italiano
Contact Gianfranco Parati, MD
Phone +390261911
Email gianfranco.parati@unimib.it
Status Recruiting
Phase N/A
Start date October 1, 2018
Completion date December 2024

See also
  Status Clinical Trial Phase
Active, not recruiting NCT02503943 - Effects of Incretin on the Blood Pressure and Lipid in Patients With Overweight or Obese Diabetes Phase 4
Recruiting NCT02156024 - The Short-term Efficacy of Gastrodia and Uncaria Drink in Treating Hypertension Phase 4
Completed NCT02142881 - Treatment of Masked Hypertension Phase 3
Active, not recruiting NCT04200716 - Arterial Function After Two Different Physical Exercise Intensities in Prehypertension N/A
Not yet recruiting NCT05409898 - Screening for Masked Hypertension With Smart Wearable Devices (SMART)
Withdrawn NCT04121299 - Mechanism of Masked Hypertension - Intervention Phase 3
Active, not recruiting NCT02893358 - Antihypertensive Treatment in Masked Hypertension for Target Organ Protection Phase 4
Recruiting NCT02663336 - Prevalence of Masked Hypertension in Nephrological Patients
Completed NCT04251975 - Masked Hypertensive Patients With Obstructive Sleep Apnea N/A